Black Rock Inc. Cytokinetics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 14,672,779 shares of CYTK stock, worth $503 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,672,779
Previous 12,414,773
18.19%
Holding current value
$503 Million
Previous $870 Million
8.67%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding CYTK
# of Institutions
368Shares Held
129MCall Options Held
3.62MPut Options Held
1.12M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$604 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$411 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$269 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$219 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.65MShares$125 Million4.28% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.23B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...